Substance P Modulates Bone Remodeling Properties of Murine Osteoblasts and Osteoclasts

Overview

Journal Sci Rep

Specialty Science

Date 2018 Jun 17

PMID 29907830

Citations 28

Authors

Tanja Niedermair

Stephan Schirner

Raphael Seebroker

Rainer H Straub

Susanne Grassel

Affiliations

Soon will be listed here.

Abstract

Clinical observations suggest neuronal control of bone remodeling. Sensory nerve fibers innervating bone, bone marrow and periosteum signal via neurotransmitters including substance P (SP). In previous studies we observed impaired biomechanical and structural bone parameters in tachykinin (Tac) 1-deficient mice lacking SP. Here, we aim to specify effects of SP on metabolic parameters of bone marrow macrophage (BMM)/osteoclast cultures and osteoblasts isolated from Tac1-deficient and wildtype (WT) mice. We demonstrated endogenous SP production and secretion in WT bone cells. Absence of SP reduced bone resorption rate, as we found reduced numbers of precursor cells (BMM) and multinucleated osteoclasts and measured reduced cathepsin K activity in Tac1-/- BMM/osteoclast cultures. However, this might partly be compensated by reduced apoptosis rate and increased fusion potential of Tac1-/- precursor cells to enlarged "super" osteoclasts. Contrarily, increased ALP enzyme activity and apoptosis rate during early osteoblast differentiation accelerated osteogenesis and cell death in the absence of SP together with reduced ALP activity of Tac1-/- osteoblasts during late osteogenic differentiation resulting in reduced bone formation at later stages. Therefore, we suggest that absence of SP presumably results in a slight reduction of bone resorption rate but concomitantly in a critical reduction of bone formation and mineralization rate.

Citing Articles

Effects of intra-articular applied rat BMSCs expressing alpha-calcitonin gene-related peptide or substance P on osteoarthritis pathogenesis in a murine surgical osteoarthritis model.

Stockl S, Taheri S, Maier V, Asid A, Toelge M, Clausen-Schaumann H Stem Cell Res Ther. 2025; 16(1):117.

PMID: 40045368 PMC: 11884178. DOI: 10.1186/s13287-025-04155-2.

The effect of prenatal fumonisin B exposure on bone innervation in newborn Wistar rats.

Tomaszewska E, Dobrowolski P, Dajnowska A, Arbatowska L, Puzio I, Rudyk H J Vet Res. 2025; 68(4):633-642.

PMID: 39776677 PMC: 11702245. DOI: 10.2478/jvetres-2024-0056.

Skeletal interoception and prospective application in biomaterials for bone regeneration.

Bai L, Li J, Li G, Zhou D, Su J, Liu C Bone Res. 2025; 13(1):1.

PMID: 39743568 PMC: 11693760. DOI: 10.1038/s41413-024-00378-w.

A bone to pick-cellular and molecular mechanisms of bone pain in sickle cell disease.

Gollamudi J, Karkoska K, Gbotosho O, Zou W, Hyacinth H, Teitelbaum S Front Pain Res (Lausanne). 2024; 4:1302014.

PMID: 38239327 PMC: 10794347. DOI: 10.3389/fpain.2023.1302014.

Research progress on the treatment of knee osteoarthritis combined with osteoporosis by single-herb Chinese medicine and compound.

Zhou G, Zhang X, Gu Z, Zhao J, Luo M, Liu J Front Med (Lausanne). 2023; 10:1254086.

PMID: 37841009 PMC: 10568449. DOI: 10.3389/fmed.2023.1254086.

References

Torii Y, Hitomi K, Yamagishi Y, Tsukagoshi N . Demonstration of alkaline phosphatase participation in the mineralization of osteoblasts by antisense RNA approach. Cell Biol Int. 1996; 20(7):459-64. DOI: 10.1006/cbir.1996.0060. View

Wittrant Y, Theoleyre S, Couillaud S, Dunstan C, Heymann D, Redini F . Regulation of osteoclast protease expression by RANKL. Biochem Biophys Res Commun. 2003; 310(3):774-8. DOI: 10.1016/j.bbrc.2003.09.084. View

Takami M, Woo J, Nagai K . Osteoblastic cells induce fusion and activation of osteoclasts through a mechanism independent of macrophage-colony-stimulating factor production. Cell Tissue Res. 1999; 298(2):327-34. DOI: 10.1007/s004419900092. View

Backman L, Danielson P . Akt-mediated anti-apoptotic effects of substance P in Anti-Fas-induced apoptosis of human tenocytes. J Cell Mol Med. 2013; 17(6):723-33. PMC: 3823176. DOI: 10.1111/jcmm.12059. View

Bjurholm A, Kreicbergs A, Brodin E, Schultzberg M . Substance P- and CGRP-immunoreactive nerves in bone. Peptides. 1988; 9(1):165-71. DOI: 10.1016/0196-9781(88)90023-x. View

Teitelbaum S . Bone resorption by osteoclasts. Science. 2000; 289(5484):1504-8. DOI: 10.1126/science.289.5484.1504. View

Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K . Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 1997; 89(5):755-64. DOI: 10.1016/s0092-8674(00)80258-5. View

Murshed M, Harmey D, Millan J, McKee M, Karsenty G . Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 2005; 19(9):1093-104. PMC: 1091743. DOI: 10.1101/gad.1276205. View

Raggatt L, Partridge N . Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 2010; 285(33):25103-8. PMC: 2919071. DOI: 10.1074/jbc.R109.041087. View

10.

Munoz M, Munoz M, Ayala A . Immunolocalization of Substance P and NK-1 Receptor in ADIPOSE Stem Cells. J Cell Biochem. 2017; 118(12):4686-4696. DOI: 10.1002/jcb.26134. View

11.

Robling A, Castillo A, Turner C . Biomechanical and molecular regulation of bone remodeling. Annu Rev Biomed Eng. 2006; 8:455-98. DOI: 10.1146/annurev.bioeng.8.061505.095721. View

12.

Eriksen E . Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord. 2010; 11(4):219-27. PMC: 3028072. DOI: 10.1007/s11154-010-9153-1. View

13.

Zimmer A, Zimmer A, Baffi J, Usdin T, Reynolds K, Konig M . Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proc Natl Acad Sci U S A. 1998; 95(5):2630-5. PMC: 19441. DOI: 10.1073/pnas.95.5.2630. View

14.

Grassel S . The role of peripheral nerve fibers and their neurotransmitters in cartilage and bone physiology and pathophysiology. Arthritis Res Ther. 2015; 16(6):485. PMC: 4395972. DOI: 10.1186/s13075-014-0485-1. View

15.

Bellucci F, Carini F, Catalani C, Cucchi P, Lecci A, Meini S . Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br J Pharmacol. 2002; 135(1):266-74. PMC: 1573107. DOI: 10.1038/sj.bjp.0704443. View

16.

Opolka A, Straub R, Pasoldt A, Grifka J, Grassel S . Substance P and norepinephrine modulate murine chondrocyte proliferation and apoptosis. Arthritis Rheum. 2011; 64(3):729-39. DOI: 10.1002/art.33449. View

17.

Jenei-Lanzl Z, Zwingenberg J, Lowin T, Anders S, Straub R . Proinflammatory receptor switch from Gαs to Gαi signaling by β-arrestin-mediated PDE4 recruitment in mixed RA synovial cells. Brain Behav Immun. 2015; 50:266-274. DOI: 10.1016/j.bbi.2015.07.020. View

18.

Hukkanen M, Konttinen Y, Rees R, Santavirta S, Terenghi G, Polak J . Distribution of nerve endings and sensory neuropeptides in rat synovium, meniscus and bone. Int J Tissue React. 1992; 14(1):1-10. View

19.

Mei G, Zou Z, Fu S, Xia L, Zhou J, Zhang Y . Substance P activates the Wnt signal transduction pathway and enhances the differentiation of mouse preosteoblastic MC3T3-E1 cells. Int J Mol Sci. 2014; 15(4):6224-40. PMC: 4013624. DOI: 10.3390/ijms15046224. View

20.

Niedermair T, Kuhn V, Doranehgard F, Stange R, Wieskotter B, Beckmann J . Absence of substance P and the sympathetic nervous system impact on bone structure and chondrocyte differentiation in an adult model of endochondral ossification. Matrix Biol. 2014; 38:22-35. DOI: 10.1016/j.matbio.2014.06.007. View